南华早报
08:22 · May 27, 2024 · Mon
制药巨头阿斯利康为何选择香港作为新的研发中心,专注于肿瘤、罕见病以及基因和细胞疗法? || Why pharmaceutical giant AstraZeneca chose Hong Kong for new R&D hub focused on oncology, rare diseases, and gene and cell therapies
via
News - South China Morning Post
(author: Morning Studio editors)
Telegraph
制药巨头阿斯利康为何选择香港作为新的研发中心,专注于肿瘤、罕见病以及基因和细胞疗法? || Why pharmaceut…
An accompanying iCampus will serve as a dynamic incubation platform for start-ups by facilitating close collaboration and partnerships with universities, innovation and technology (I&T) parks, innovators in biotech and biomedical ventures and the financial…
Home
Powered by
BroadcastChannel
&
Sepia